Pricing Log in Create free account
Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) Debt to equity

Alert me on Debt to equity

West Pharmaceutical Services, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.1×, up 0.0× from fiscal 2025 (0.1×). Over the past ten years it has ranged from 0.0× (fiscal 2023) to 0.2× (fiscal 2015); the current reading is higher than 18% of that period. That is below the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.1× (15.36%)
FY2024 0.1× 198.42%
FY2023 0.0× (67.14%)
FY2022 0.1× (13.87%)
FY2021 0.1× (34.46%)
FY2020 0.1× (15.85%)
FY2019 0.2× 15.46%
FY2018 0.1× (8.77%)
FY2017 0.2× (23.96%)
FY2016 0.2× (9.48%)

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.1× 0.15%
Mar 2026 0.1× 6.10%
Dec 2025 0.1× (3.77%)
Sep 2025 0.1× (4.05%)
42 more quarters

Against its own ten years

Low 0.0× High 0.2×
Ten-year median 0.1×
Current reading's percentile 18

Debt to equity against peers

Company Debt to equity
RMD ResMed Inc. compare 0.1×
WST West Pharmaceutical Services, Inc. 0.1×
ALC Alcon compare 0.2×
RGEN Repligen Corporation compare 0.3×
COO The Cooper Companies, Inc. compare 0.3×
BDX Becton, Dickinson and Company compare 0.6×
MDLN Medline Inc. compare 0.7×
SOLV Solventum Corporation compare 1.1×
BAX Baxter International Inc. compare 1.5×
Medical Instruments & Supplies industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on WST